MS patients may receive less frequent rituximab infusions without increasing their chances of relapse or disease progression, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback